Morgan Stanley Fulgent Genetics, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Morgan Stanley holds 467,332 shares of FLGT stock, worth $8.55 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

467,332

Previous 369,133 26.6%

Holding current value

$8.55 Million

Previous $7.24 Million 40.15%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$19.6 - $25.06 $1.92 Million - $2.46 Million	98,199 Added 26.6%	467,332 $10.2 Million
Q2 2024 Oct 17, 2024	BUY	$19.09 - $22.57 $2.84 Million - $3.36 Million	148,885 Added 67.6%	369,133 $7.24 Million
Q2 2024 Aug 14, 2024	BUY	$19.09 - $22.57 $2.84 Million - $3.36 Million	148,885 Added 67.6%	369,133 $7.24 Million
Q1 2024 Oct 17, 2024	SELL	$21.55 - $29.29 $3.21 Million - $4.36 Million	-148,885 Reduced 40.33%	220,248 $4.78 Million
Q1 2024 Aug 16, 2024	SELL	$21.55 - $29.29 $927,468 - $1.26 Million	-43,038 Reduced 16.35%	220,248 $4.78 Million
Q1 2024 May 15, 2024	SELL	$21.55 - $29.29 $927,468 - $1.26 Million	-43,038 Reduced 16.35%	220,248 $4.78 Million
Q4 2023 Aug 16, 2024	SELL	$23.64 - $30.27 $2.5 Million - $3.2 Million	-105,847 Reduced 28.67%	263,286 $7.61 Million
Q4 2023 Feb 13, 2024	BUY	$23.64 - $30.27 $305,641 - $391,360	12,929 Added 5.16%	263,286 $7.61 Million
Q3 2023 Nov 15, 2023	BUY	$26.74 - $40.81 $795,488 - $1.21 Million	29,749 Added 13.49%	250,357 $6.69 Million
Q2 2023 Aug 14, 2023	SELL	$28.52 - $40.7 $2.35 Million - $3.35 Million	-82,299 Reduced 27.17%	220,608 $8.17 Million
Q1 2023 May 15, 2023	BUY	$29.39 - $36.27 $1.14 Million - $1.41 Million	38,819 Added 14.7%	302,907 $9.46 Million
Q4 2022 Feb 14, 2023	SELL	$29.23 - $40.28 $736,566 - $1.02 Million	-25,199 Reduced 8.71%	264,088 $7.86 Million
Q3 2022 Nov 14, 2022	BUY	$37.92 - $63.74 $1.79 Million - $3.01 Million	47,227 Added 19.51%	289,287 $11 Million
Q2 2022 Oct 27, 2022	BUY	$47.98 - $62.75 $1.36 Million - $1.77 Million	28,270 Added 13.22%	242,060 $13.2 Million
Q2 2022 Aug 15, 2022	BUY	$47.98 - $62.75 $1.36 Million - $1.77 Million	28,270 Added 13.22%	242,060 $13.2 Million
Q1 2022 Oct 27, 2022	SELL	$49.85 - $96.11 $1.41 Million - $2.72 Million	-28,270 Reduced 11.68%	213,790 $13.3 Million
Q1 2022 May 13, 2022	BUY	$49.85 - $96.11 $1.86 Million - $3.58 Million	37,266 Added 21.11%	213,790 $13.3 Million
Q4 2021 Feb 14, 2022	BUY	$77.3 - $105.0 $996,319 - $1.35 Million	12,889 Added 7.88%	176,524 $17.8 Million
Q3 2021 Nov 15, 2021	BUY	$74.87 - $110.87 $12.3 Million - $18.1 Million	163,635 New	163,635 $14.7 Million

Others Institutions Holding FLGT

# of Institutions

201

Shares Held

16.1M

Call Options Held

2.04M

Put Options Held

14K

View Full List

About Fulgent Genetics, Inc.

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $554M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

More about FLGT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account